Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245

Blood

Volumn 114, Issue 25, 2009, Pages 5182-5190

  Bari, Rafijul ^a   Bell, Teresa ^a   Leung, Wai Hang ^a   Vong, Queenie P ^a   Chan, Wing Keung ^a   Das Gupta, Neha ^a   Holladay, Martha ^a   Rooney, Barbara ^a   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA ARRESTIN 2; CYSTEINE; GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG; BETA ARRESTIN; GREEN FLUORESCENT PROTEIN; HLA C ANTIGEN; HLA CW6; HLA-CW6; KIR2DL1 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; RETINA S ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; DOWN REGULATION; ENZYME INHIBITION; GENE FREQUENCY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; SYNAPSE; ALLELE; CYTOTOXICITY TEST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MUTATION; NATURAL KILLER CELL; PHYSIOLOGY; TUMOR CELL LINE;

ALLELES; ARGININE; ARRESTINS; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HLA-C ANTIGENS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MICROSCOPY, FLUORESCENCE; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, KIR2DL1; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 73949107886     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-231977     Document Type: Article

References (47)

1. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
2. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008;9(5): 495-502.
3. Tassi I, Klesney-Tait J, Colonna M. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse. Immunol Rev. 2006;214:92-105.
4. Bryceson YT, Long EO. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol. 2008;20(3):344-352.
5. Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155-160.
6. Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today. 1996;17(2):100.
7. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin Immunol. 2008;20(6):311-316.
8. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006;7: 277-300.
9. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002;190:40-52.
10. Robinson J, Marsh SG. IPD: the Immuno Polymorphism Database. Methods Mol Biol. 2007; 409:61-74.
11. Steiner NK, Dakshanamurthy S, VandenBussche CJ, Hurley CK. Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics. 2008;60(11):655-667.
12. Goodridge JP, Lathbury LJ, Steiner NK, et al. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol. 2007;37(1):199-211.
13. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med. 2006;203(3):633-645.
14. Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLABw4 ligand. J Immunol. 2005;175(8):5222-5229.
15. Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood. 2008;112(2):435-443.
16. O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol. 2007;178(1):235-241.
17. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008;20(6):343-352.
18. Velardi A, Ruggeri L, Alessandro Moretta Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 2002; 23(9):438-444.
19. Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol. 2004;172(1):644-650.
20. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature. 2000;405(6786):537-543.
21. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol. 2001; 2(5):452-460.
22. Leung W, Iyengar R, Triplett B, et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol. 2005;174(10):6540-6545.
23. Bari R, Zhang YH, Zhang F, et al. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol. 2009;174(2):647-660.
24. Fassett MS, Davis DM, Valter MM, Cohen GB, Strominger JL. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A. 2001;98(25):14547-14552.
25. European Bioinformatics Institute. Immuno Poly-morphism Disease (IPD) KIR database. http:// www.ebi.ac.uk/ipd/kir. Accessed April 10, 2009.
26. Rubio V, Stuge TB, Singh N, et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med. 2003;9(11):1377-1382.
27. Yu MC, Su LL, Zou L, et al. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol. 2008;9(8):898-907.
28. Lou Z, Jevremovic D, Billadeau DD, Leibson PJ. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med. 2000;191(2):347-354.
29. Huard B, Karlsson L. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement. Nature. 2000;403(6767): 325-328.
30. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol. 2008;180(6):3969-3979.
31. Cosson P, Lankford SP, Bonifacino JS, Klausner RD. Membrane protein association by potential intramembrane charge pairs. Nature. 1991; 351(6325):414-416.
32. Alcover A, Mariuzza RA, Ermonval M, Acuto O. Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. J Biol Chem. 1990; 265(7):4131-4135.
33. Fuller-Espie S, Hoffman Towler P, Wiest DL, Tietjen I, Spain LM. Transmembrane polar residues of TCR beta chain are required for signal transduction. Int Immunol. 1998;10(7):923-933.
34. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosinebased activation motif is involved in activating NK cells. Nature. 1998;391(6668):703-707.
35. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 1997;158(11):5083-5086.
36. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol. 1994;12:555-592.
37. Franceschi DS, Mazini PS, Rudnick CC, et al. Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. Tissue Antigens. 2008;72(5):478-482.
38. Miyashita R, Tsuchiya N, Yabe T, et al. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum. 2006;54(3):992-997.
39. Zhang C, Maeda N, Izumiya C, et al. Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol. 2006;55(2):106-114.
40. Gazit R, Garty BZ, Monselise Y, et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood. 2004;103(5):1965-1966.
41. Levinson RD, Du Z, Luo L, et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008; 9(3):249-258.
42. Carrington M, Wang S, Martin MP, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med. 2005;201(7):1069-1075.
43. Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer. 2007;97(4):539-542.
44. Junevik K, Werlenius O, Hasselblom S, Jacobsson S, Nilsson-Ehle H, Andersson PO. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Ann Hematol. 2007;86(2):89-94.
45. Ludajic K, Balavarca Y, Bickeboller H, et al. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009;44(2):97-103.
46. Meenagh A, Gonzalez A, Sleator C, McQuaid S, Middleton D. Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1. Tissue Antigens. 2008; 72(4):383-391.
47. Bioinformatics.NMDP.org. High Resolution HLA Alleles and Haplotypes in the US Population. http://bioinformatics.nmdp.org/HLA/Haplotype-Frequencies/ index.html?src=review. Accessed September 10, 2009.